Karin Hoelzer
Senior Director, Patient Advocacy,
Biotechnology Innovation Organization (BIO)
United States
Karin Hoelzer currently serves as the Senior Director of Patient Advocacy at the Biotechnology Innovation Organization, a position held since October 2024. Previously, Karin held the role of Senior Director of Policy and Regulatory Affairs at the National Organization for Rare Disorders from July 2022 to October 2024. Karin's experience also includes serving as Senior Director of Public Health Data Analytics at Maximus, and roles at The Pew Charitable Trusts, where Karin advanced from Officer to Senior Officer in Health Programs between 2015 and July 2020. Early career positions included an ORISE fellow at the FDA, a Research Associate at Cornell University, and various internships in the pharmaceutical and veterinary fields. Karin holds a Ph.D. in Comparative Biomedical Sciences from Cornell University and a Doctor of Veterinary Medicine from the University of Veterinary Medicine Hannover, with additional study at Ecole nationale vétérinaire de Lyon.
Sessions
-
16-Jun-2025210AThe Priority Review Voucher Program: Incentivizing Neglected Disease Research and Promoting Biotech Investment and Development for More than a Decade
-
17-Jun-2025206ABOvercoming Economic Challenges to Rare Disease Drug Development
-
18-Jun-2025Storytelling Stage (Booth #349)The Disorder Channel Film - RARE HUMANS: Turning Hope into Action
-
19-Jun-2025208The Power to Shape the Future


